Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 027804/0567 | |
| Pages: | 8 |
| | Recorded: | 03/05/2012 | | |
| Attorney Dkt #: | PB63882 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/05/2014
|
Application #:
|
13389525
|
Filing Dt:
|
03/05/2012
|
| | | | | | |
PCT #:
|
EP1062420
|
|
Title:
|
CRYSTALLINE 2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-N-(4-(4-FLUORO-2-METHYLPHENYL)-6-((7S,9AS)-7-(HYDROXYMETHYL)HEXAHYDROPYRAZINO[2,1-C][1,4]OXAZIN-8(1H)-YL)PYRIDIN-3-YL)-N,2-DIMETHYL-PROPANAMIDE OF THE FORMULA (I), THEIR USE IN THERAPY, AND PROCESS FOR THE PREPARATION OF THE SAME.
|
|
|
Assignee
|
|
|
|
|
| ONE FRANKLIN PLAZA, 200 NORTH 16TH STREET |
| PHILADELPHIA, PENNSYLVANIA 19102 |
|
|
Correspondence name and address
|
| |
GLAXOSMITHKLINE
|
| |
FIVE MOORE DRIVE
|
| |
C2111.2F
|
| |
RESEARCHTRIANGLEPARK, NC 27709
|
Search Results as of:
06/06/2024 02:24 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
